{"id":"scilinm30","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a fixed-ratio insulin mixture containing 30% rapid-acting insulin and 70% intermediate-acting insulin (NPH). It provides both immediate postprandial glucose control and basal insulin coverage, mimicking physiological insulin secretion patterns. The combination allows for simplified dosing regimens in patients requiring insulin therapy.","oneSentence":"Scilin®M30 is a premixed insulin formulation that combines rapid-acting and intermediate-acting insulin to control blood glucose in diabetes.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:37:32.691Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"},{"name":"Type 1 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT01338376","phase":"PHASE4","title":"Organization Program of DiabEtes INsulIN ManaGement","status":"UNKNOWN","sponsor":"Chinese Diabetes Society","startDate":"2011-03","conditions":"Type 2 Diabetes Mellitus","enrollment":1500}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Scilin®M30","genericName":"Scilin®M30","companyName":"Chinese Diabetes Society","companyId":"chinese-diabetes-society","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Scilin®M30 is a premixed insulin formulation that combines rapid-acting and intermediate-acting insulin to control blood glucose in diabetes. Used for Type 2 diabetes mellitus, Type 1 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}